Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | +8.81% | -1.14% | +200.87% |
05-31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
05-31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
Sales 2024 * | 671K 52.69M | Sales 2025 * | - | Capitalization | 445M 34.94B |
---|---|---|---|---|---|
Net income 2024 * | -59M -4.63B | Net income 2025 * | -81M -6.36B | EV / Sales 2024 * | 663 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.98
x | P/E ratio 2025 * |
-5.9
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.37% |
Latest transcript on Ocugen, Inc.
1 day | +8.81% | ||
1 week | -1.14% | ||
1 month | +31.06% | ||
3 months | +84.83% | ||
6 months | +347.38% | ||
Current year | +200.87% |
Managers | Title | Age | Since |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 31/12/12 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 16/03/22 | |
Director/Board Member | 74 | 04/04/20 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 26/09/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 1,487 M€ | +7.77% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 1.73 | +8.81% | 4,361,999 |
30/05/24 | 1.59 | -2.45% | 4,640,939 |
29/05/24 | 1.63 | -4.68% | 4,495,999 |
28/05/24 | 1.71 | -2.29% | 5,474,849 |
24/05/24 | 1.75 | -1.69% | 3,667,229 |
Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.87% | 445M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- OCGN Stock